A Study of SVZ Irradiation With Postoperative Radiotherapy in Patients With GBM.

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2025

Conditions
GBM
Interventions
RADIATION

Postoperative radiotherapy for SVZ

GBM patients who met the inclusion criteria received radiotherapy range and dose based on the EORTC outline principles. The ipsilateral and contralateral SVZ areas received 56Gy and 40Gy respectively, with a fractionated dose of 2Gy. Concurrent chemotherapy with temozolomide and six cycles of adjuvant temozolomide chemotherapy were performed at the same time as radiotherapy.

Trial Locations (1)

210009

RECRUITING

Lining Guo, Nanjing

All Listed Sponsors
lead

Jiangsu Cancer Institute & Hospital

OTHER